26choiceM

S&P 500 potential EPS growth paths from COVID19 growth shock

Equities 6 minutes to read

Summary:  The COVID-19 virus may have little impact on long-term earnings growth even if the short impact could prove quite large. In order to evaluate the outlook for the S&P 500 investors must focus on the potential hit to the short-term earnings outlook and animal spirits, or risk aversion. We provide a crude model for predicting future EPS for the S&P 500 based on two GDP growth shock scenarios. It shows that the S&P 500 could be in for a tough two years in a worst-case scenario.


In yesterday’s equity update we went through the different factors that have an impact on equities and how they stack up after last week’s carnage. Our main message is that indicators suggest more pain ahead for equities, but overall any prediction comes with high degree of uncertainty. It all comes down to whether the COVID-19 virus can be contained or not. Equities reflect discounting of future cash flows and thus COVID-19 impact on those cash flows is necessary to quantify in order to make judgements on S&P 500 being mispriced or not. The long-term growth rate for profits are not impacted by a virus so the key is the short-term impact over the next two years. In this update we try to make a crude model for EPS path off two scenario of growth shocks from the COVID-19 outbreak.

Model assumptions

The model assumes that quarterly changes in S&P 500 12-month trailing log EPS can be modelled using US GDP growth y/y and quarterly changes in GDP growth. The is very crude and other variables obviously play a role, but we will get back to that later. Our model is a quantile regression model in order to capture quantile effects and not just the mean response. This provides us with a framework for assessing the prediction interval in an extreme event. We use data from Q1 1954 to fit the quantile regression.

GDP growth scenarios

Our two growth scenarios are called base- and worst-case and try to capture a “mild” shock taking US GDP growth briefly to zero percent followed up by a quick rebound to trend growth with a slight overshooting due to pent-up demand in the economy (think post 2008 financial crisis). The worst-case scenario assumes a significant GDP growth shock taking the growth rate from 2.3% in Q4 2018 to -2% by Q4 2019 superseded by a slower recovery not taking GDP growth back to trend until sometime in early 2022.

3_PG_1

Potential S&P 500 EPS paths

In the base-case scenario the median of the predicted distributions of EPS is more or less flat in 2019 before growing slightly in 2020 leading to a three-year period (2018-2021) of stagnating EPS growth for the S&P 500. In this scenario risk aversion would likely increase holding back any earnings multiple expansion. In the worst-case scenario the median path takes down EPS by 10.5% which significantly more than the 6.2% EPS decline during the China/EM slowdown in 2015-2016 but nothing like the 49% decline during the financial crisis.

3_PG_2

The plot also shows the 25% and 75% percentile paths for the two scenarios. The first observation is that that potential range of outcomes is large in both cases which reflects that our two variables cannot fully explain quarterly variance in earnings. This leads us to the next phase which is where art takes over from the model. Where do we think the EPS path ends up in the predicted distributions?

Our naïve forecast is that the “true” GDP growth path will be something in the middle of our two scenarios based on our view that the virus will almost impossible to contain and that human behaviour in a global pandemic will create a significant demand shock to the economy. Most of the unknowns related to COVID-19 have larger downside than upside risks and thus our view is that the EPS path could end up around the 25% percentile. Taking the average of the two scenarios put the EPS decline over the next two years at minus 28%. This very negative outlook reflect severe nonlinear effects on the downside from human behaviour (demand shock) and as a result credit events (bankruptcies, investment shock), and lastly prolonged supply disruption in a global supply chain that has not spread its production capacity risk properly but concentrated it in Asia.

Impact on S&P 500

The average of the two 25% percentile EPS paths translate into S&P 500 EPS at $108.76 by Q4 2021. Since 1954 the average P/E ratio has been 16.6, but if we assume that the P/E ratio will only contract from current levels to around 18x as low yields and low inflation have a positive impact on the earnings multiple then the impact on the S&P 500 will be significant.

This earnings multiple combined with EPS tracking the average of the two 25% percentile paths leads to S&P 500 at around 2000 in Q4 2021 (that’s 35% below today’s level). If we use the average of the two median paths then EPS will be $145.93 in Q4 2021 and with an earnings multiple of 18x then S&P 500 is priced at around 2600 (that’s 16% below today’s level).

You may think it sounds a bit too crazy but remember that the dynamite here is a valuation multiple contraction reflecting an impact on risk aversion by investors. If you believe P/E ratio will stay unchanged then of course the impact on S&P 500 will be significantly less from current levels. But remember we don’t know the future. This is an exercise in risk management and providing a broader spectrum of outcomes than what you are probably thinking.

Our next update will go through a multi-stage growth model for pricing S&P 500 to see what the current decline in S&P 500 tells us of the market pricing of the expected earnings decline.

Disclaimer

Confidentiality and Usage:
You may not reproduce, distribute, or transmit this material or any portion thereof without prior written permission from Saxo.

Nature of Information:
The information provided herein is based on current market conditions and analysts' opinions, which may reflect personal views of the author, and are subject to change without notice. This material does not include a record of any trading prices, or an offer of, or solicitation for, or endorsement to enter into any transaction in any investment product. Any forecast on the economy, markets and economic trends of the markets provided is not necessarily indicative of the future or likely performance of the investment product subject of this material.

Responsibility and Liability:
Saxo accepts no liability for any use that may be made of these comments or for any consequences that arise from such use. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

The information provided in this material is solely for information only. It is intended for general circulation and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. Accordingly, it should not be relied on or treated as a substitute for specific advice concerning specific situations of any person. Please seek advice from a financial adviser regarding the suitability of any investment product taking into account your specific investment objectives, financial situation or particular needs before you make a commitment to purchase an investment product. In the event that you choose not to seek advice from a financial adviser, you should consider whether any investment product mentioned in this publication is suitable for you.

Notwithstanding the above, insofar as any information provided herein contains research analyses or reports concerning any investment product authored by any foreign research house and is issued or promulgated to a person in Singapore who is not an accredited investor, expert investor, and/or institutional investor, Saxo Capital Market Pte. Ltd. accepts legal responsibility for the contents of this material to the extent required by law. Recipients of such material are to contact Saxo Capital Markets Pte. Ltd. in respect of any matters arising from, or in connection with, this material.

Risk Disclosure:
Trading in investment products involve significant risk, including the risk of losing your entire investment. Historical returns are not a guarantee of future returns. Prices can both rise and fall, and there is a risk that you will not get back the money you invested.

Conflicts of interest:
The author may hold positions in the investment products mentioned. The author does not own positions in the underlying investment product exceeding 0.5% of its market capitalisation, save as otherwise declared. The author is not permitted to trade the mentioned investment products within the first 24 hours after the publication of this article.

Saxo maintains partnerships with companies that compensate Saxo for promotional activities conducted on its platform. Additionally, Saxo has agreements with certain partners who provide retrocession contingent upon clients purchasing specific investment products offered by these partners. While Saxo receives compensation from these partnerships, all content is conducted with the intention of providing clients with valuable options and information.

Publication details:
If any listed companies are the subject of the material, the content has not been submitted to the companies in question prior to publication.

Please refer to our full disclaimer and notification on non-independent investment research for more details.

Saxo Markets
88 Market Street
CapitaSpring #31-01
Singapore 048948

Contact Saxo

Singapore
Singapore

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Saxo is part of the J. Safra Sarasin Group.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website are not intended for residents of the United States, Malaysia and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

Apple and the Apple logo are trademarks of Apple Inc, registered in the US and other countries and regions. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.